| 935 |
occurrence |
toll-like receptor 7 signaling pathway
(GO:0034154)
|
viral genome
(GO:0019015)
|
None
|
| 934 |
occurrence |
toll-like receptor 3 signaling pathway
(GO:0034138)
|
viral genome
(GO:0019015)
|
None
|
| 933 |
occurrence |
inhibition of host DNA replication by virus
(GO:0098673)
|
interferon regulatory factor 3 complex
(GO:0097072)
|
None
|
| 932 |
occurrence |
membrane fusion
(GO:0061025)
|
vesicle membrane
(GO:0012506)
|
2159: Influenza A virus (IAV) cell entry
|
| 931 |
occurrence |
receptor-mediated endocytosis
(GO:0006898)
|
influenzavirus hemagglutinin
(PR:000049750)
|
2159: Influenza A virus (IAV) cell entry
|
| 930 |
occurrence |
protein localization to endosome
(GO:0036010)
|
clathrin-coated vesicle membrane
(GO:0030665)
|
2159: Influenza A virus (IAV) cell entry
|
| 929 |
occurrence |
receptor-mediated endocytosis
(GO:0006898)
|
clathrin-coated vesicle membrane
(GO:0030665)
|
None
|
| 928 |
occurrence |
receptor binding
(GO:0005102)
|
|
3 Events
|
| 927 |
disrupted |
intercellular transport
(GO:0010496)
|
|
2096: Occurrence, (Micro)vascular dysfunction
|
| 926 |
functional change |
|
smooth muscle cell
(CL:0000192)
|
2096: Occurrence, (Micro)vascular dysfunction
|
| 925 |
functional change |
|
pericyte cell
(CL:0000669)
|
2096: Occurrence, (Micro)vascular dysfunction
|
| 924 |
functional change |
|
blood vessel endothelial cell
(CL:0000071)
|
2096: Occurrence, (Micro)vascular dysfunction
|
| 923 |
decreased |
signaling
(GO:0023052)
|
neurotransmitter
(CHEBI:25512)
|
2151: Disruption, neurotransmitter release
|
| 922 |
increased |
calcium amount
(VT:0010499)
|
calcium(2+)
(CHEBI:29108)
|
1339: Increase, intracellular calcium
|
| 921 |
increased |
kinase activity
(GO:0016301)
|
astrocyte
(CL:0000127)
|
2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
|
| 920 |
increased |
Insulin resistance
(HP:0000855)
|
|
2119: Increase, Insulin resistance
|
| 919 |
increased |
respiratory electron transport chain
(GO:0022904)
|
superoxide
(CHEBI:18421)
|
2120: Superoxide generation, increased
|
| 918 |
decreased |
succinate metabolic process
(GO:0006105)
|
succinate dehydrogenase complex
(GO:0045281)
|
2118: Succinate dehydrogenase, inhibited
|
| 917 |
decreased |
FAD metabolic process
(GO:0046443)
|
succinate dehydrogenase complex
(GO:0045281)
|
2118: Succinate dehydrogenase, inhibited
|
| 916 |
decreased |
succinate dehydrogenase activity
(GO:0000104)
|
|
2118: Succinate dehydrogenase, inhibited
|
| 915 |
increased |
blood coagulation, fibrin clot formation
(GO:0072378)
|
Fibrin
(CHEBI:5054)
|
1846: Thrombosis and Disseminated Intravascular Coagulation
|
| 914 |
decreased |
fibrinolysis
(GO:0042730)
|
|
1846: Thrombosis and Disseminated Intravascular Coagulation
|
| 913 |
decreased |
fibrinolysis
(GO:0042730)
|
Fibrin
(CHEBI:5054)
|
None
|
| 912 |
occurrence |
abnormal blood coagulation
(MP:0002551)
|
blood
(UBERON:0000178)
|
1845: Coagulation
|
| 911 |
decreased |
abnormal glutathione level
(MP:0012603)
|
glutathione
(CHEBI:16856)
|
130: Depletion, GSH
|